Lazard Ltd, together with its subsidiaries, operates as a financial advisory and asset management firm in North America, Europe, Asia, Australia, and Central and South America. Its Financial Advisory segment offers various financial advisory services regarding mergers and acquisitions, capital advisory, restructurings, shareholder advisory, sovereign advisory, capital raising, and other strategic advisory matters. This segment serves corporate, partnership, institutional, government, sovereign, and individual clients across various industry areas, including consumers, financial institutions, healthcare and life sciences, industrials, power and energy/infrastructure, and real estate, as well as technology, media, and telecommunications. The company's Asset Management segment offers a range of investment solutions and investment management services in equity and fixed income strategies; asset allocation strategies; and alternative investments and private equity funds to corporations, public funds, sovereign entities, endowments and foundations, labor funds, financial intermediaries, and private clients. Lazard Ltd was founded in 1848 and is based in Hamilton, Bermuda.
IPO Year: 2005
Exchange: NYSE
Website: lazard.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2025 | $56.00 → $33.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/3/2025 | Outperform → Peer Perform | Wolfe Research | |
| 12/20/2024 | $65.00 → $57.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/9/2024 | $60.00 → $63.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/12/2024 | $51.00 | Equal Weight | Wells Fargo |
| 1/29/2024 | $51.00 | Outperform | Keefe Bruyette |
| 1/3/2024 | $42.00 | Peer Perform → Outperform | Wolfe Research |
| 9/19/2023 | $37.00 → $32.00 | Neutral → Sell | Goldman |
| 7/13/2023 | $31.00 → $36.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 7/12/2023 | $36.00 → $43.00 | Equal-Weight → Overweight | Morgan Stanley |
Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously
Wolfe Research downgraded Lazard from Outperform to Peer Perform
Keefe Bruyette downgraded Lazard from Outperform to Mkt Perform and set a new price target of $57.00 from $65.00 previously
Morgan Stanley downgraded Lazard from Overweight to Equal-Weight and set a new price target of $63.00 from $60.00 previously
Wells Fargo initiated coverage of Lazard with a rating of Equal Weight and set a new price target of $51.00
Keefe Bruyette resumed coverage of Lazard with a rating of Outperform and set a new price target of $51.00
Wolfe Research upgraded Lazard from Peer Perform to Outperform and set a new price target of $42.00
Goldman downgraded Lazard from Neutral to Sell and set a new price target of $32.00 from $37.00 previously
Keefe Bruyette upgraded Lazard from Underperform to Mkt Perform and set a new price target of $36.00 from $31.00 previously
Morgan Stanley upgraded Lazard from Equal-Weight to Overweight and set a new price target of $43.00 from $36.00 previously